Get started
Author

Enes Yeşilbaş

Observed names: E. Yesilbas, Enes YEŞİLBAŞ, Enes Yesilbas, Enes Yesılbas, Enes Yeşi̇lbaş
ORCID: 0000-0002-0947-702X
Observed ORCID: 0000-0002-0947-702X
OpenAlex ID: A5116305254
Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trial
2025 · Orhun Akdogan, Galip Can Uyar, et al. · European Journal of Cancer · 45
Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores
2025 · Galip Can Uyar, Oriol Mirallas, et al. · The Lancet Regional Health - Europe · 11
PDF
Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)
2025 · Galip Can Uyar, Beyza Nur Başaran, et al. · Clinical Colorectal Cancer · 6
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025 · Salih Tunbekici, Gokhan Sahin, et al. · International Journal of Cancer · 3
Impact of vitamin D deficiency and inflammatory biomarkers on pathological response to neoadjuvant chemotherapy in breast cancer
2026 · Kadriye Başkurt, Galip Can Uyar, et al. · Clinical & Translational Oncology · 2
Prognostic significance of liver-to-muscle FDG uptake ratio and ınflammatory biomarkers in small cell lung cancer
2025 · Kadriye Başkurt, Semra Demirtaş Şenlik, et al. · Clinical & Translational Oncology · 2
Limb Compression Therapy and Chemotherapy‐Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self‐Controlled Study( NEURO ‐ GLOVE Trial)
2026 · Kadriye Başkurt, Galip Can Uyar, et al. · International Journal of Cancer · 1
Inflammatory and Nutritional Biomarkers Predict Response to Neoadjuvant Dual Anti-HER2 Therapy in HER2-Positive Breast Cancer: A Retrospective Cohort Study
2026 · Hayriye Şahinli, Galip Can Uyar, et al. · Cancer Management and Research · 1
The Impact of Systemic Inflammation and Nutritional Indicators on Progression-Free Survival in Patients with Metastatic Clear Cell Renal Carcinoma Receiving First-Line Tyrosine Kinase Inhibitor Therapy
2025 · Galip Can Uyar, Güner Akgüner, et al. · Turkish Journal of Clinics and Laboratory · 1
PDF
Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real‑world experience
2026 · Kadriye Başkurt, Galip Uyar, et al. · Oncology Letters
PDF
Prognostic value of the lymphocyte‑albumin‑neutrophil ratio in de novo metastatic colorectal cancer: A continuous‑variable analysis
2026 · Enes Yeşi̇lbaş, Gali̇p Uyar, et al. · Oncology Letters
PDF
Temporal Trends and Demographic Disparities in Prostate Cancer Mortality in the United States, 1999-2020: A CDC WONDER Analysis
2026 · Enes Yeşilbaş, Galip Can Uyar, et al. · Acta haematologica oncologica Turcica.
PDF
Histologic Subtypes, Treatment Patterns, and Survival Outcomes in Cervical Cancer: A Population-based SEER Study
2026 · Kadriye Başkurt, Galip Can Uyar, et al. · Acta haematologica oncologica Turcica.
PDF
Clinicopathologic Characteristics, Treatment Patterns, and Survival Outcomes in Malignant Mesothelioma: A Population-based SEER Study, 2004-2023
2026 · Enes YEŞİLBAŞ, Galip Can UYAR, et al. · Journal of Oncological Sciences
PDF
Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation
2026 · Galip Can Uyar, Kadriye Başkurt, et al. · The Oncologist
PDF
Comment on: “The effect of cancer response style on anxiety and depression levels in newly diagnosed lung cancer patients”
2026 · Enes Yeşilbaş, Galip Can Uyar, et al. · Supportive Care in Cancer
Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study
2026 · Galip Can Uyar, Kadriye Başkurt, et al. · The Breast
PDF
Wearable-derived postdischarge mobility as a digital biomarker for 90-day readmission and mortality in metastatic cancer
2026 · Orhun Akdogan, Galip Can Uyar, et al. · Supportive Care in Cancer
Association between PhenoAge-assessed biological age and survival outcomes in solid tumor patients treated with immune checkpoint inhibitors
2026 · Tuba Uğur Tuzcu, Enes Yeşilbaş, et al. · Discover Oncology
Post-Recurrence Outcomes Associated with a Bevacizumab-Containing First-Recurrence Strategy in Glioblastoma: A Propensity-Weighted Single-Center Cohort Study with Competing-Risk Analysis
2026 · Enes Yeşilbaş, Sema Sezgin Göksu · Cancers
Topical Diclofenac for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Prospective Real-World Study
2026 · Orhun Akdogan, Sevgi Eryildiz Yucel, et al. · JCO Global Oncology
Peer-led culinary workshops for cancer survivors: feasibility achieved, but stronger nutritional and evaluative foundations are required
2026 · Galip Can Uyar, Enes Yeşilbaş, et al. · Supportive Care in Cancer
Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey
2026 · Kadriye Başkurt, Orhun Akdoğan, et al. · Current Oncology
Limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers: A prospective self-controlled study (NEURO-GLOVE Trial)—Updated long-term analysis.
2026 · Kadriye Başkurt, Galip Can Uyar, et al. · Journal of Clinical Oncology
Integrated assessment of cachexia, body composition, and patient-reported outcomes in unplanned hospitalizations of patients with metastatic cancer (PRO-HAND study).
2026 · Enes Yeşi̇lbaş, Galip Can Uyar, et al. · Journal of Clinical Oncology
Works count: 45
Citation count: 72
H-index: 3
I10-index: 2
Year
Topic
Type